Michel Lagarde - 01 May 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Reporting relationship
Director
Issuer ticker
VRTX
Reported as of
01 May 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 May 2026, 17:06:54 UTC
Prior SEC filing
02 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christiana Stevenson, Attorney-in-Fact

Key filing fact

Michel Lagarde filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 05 May 2026.

Key facts

  • This page summarizes Michel Lagarde's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 May 2026, 17:06.

Change

  • Previous filing in this sequence was filed on 02 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001518973 Primary reporting owner

Lagarde Michel

Relationship
Director
Address
C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Signature date
05 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+2,866
Change %
Price
$0.000000*
Shares after
2,866
Date
01 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,866
Exercise price
$424.45
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .